Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,676 | 92 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Shire North American Group Inc | $331.43 | 21 | $0 (2019) |
| CooperVision Inc. | $307.41 | 16 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $166.34 | 9 | $0 (2023) |
| Alcon Vision LLC | $136.54 | 5 | $0 (2024) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $116.83 | 8 | $0 (2021) |
| Allergan Inc. | $116.07 | 2 | $0 (2017) |
| Johnson & Johnson Vision Care, Inc. | $96.14 | 6 | $0 (2024) |
| Oyster Point Pharma, Inc. | $95.87 | 6 | $0 (2024) |
| Alcon Laboratories Inc | $93.38 | 7 | $0 (2018) |
| Valeant Pharmaceuticals North America LLC | $61.93 | 4 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $315.87 | 10 | CooperVision Inc. ($110.83) |
| 2023 | $87.87 | 5 | Novartis Pharmaceuticals Corporation ($29.37) |
| 2022 | $131.49 | 8 | Oyster Point Pharma, Inc. ($39.13) |
| 2021 | $132.16 | 7 | Novartis Pharmaceuticals Corporation ($103.34) |
| 2020 | $28.06 | 2 | Novartis Pharmaceuticals Corporation ($15.69) |
| 2019 | $178.40 | 12 | CooperVision Inc. ($45.39) |
| 2018 | $329.72 | 22 | Shire North American Group Inc ($128.28) |
| 2017 | $472.90 | 26 | Shire North American Group Inc ($163.02) |
All Payment Transactions
92 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/16/2024 | CooperVision Inc. | Clariti Contact Lens (Device) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: Devices | ||||||
| 08/15/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: OPTOMETRY | ||||||
| 06/25/2024 | Alcon Vision LLC | TOTAL30 (Device) | Food and Beverage | In-kind items and services | $85.55 | General |
| Category: Ophthalmology | ||||||
| 06/19/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Ophthalmology | ||||||
| 06/05/2024 | Johnson & Johnson Vision Care, Inc. | — | Food and Beverage | In-kind items and services | $22.36 | General |
| 04/25/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Dry eyes | ||||||
| 04/18/2024 | CooperVision Inc. | MyDay Contact Lens (Device) | Food and Beverage | In-kind items and services | $72.40 | General |
| Category: Devices | ||||||
| 03/25/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: SOLUTION/ DROPS | ||||||
| 03/19/2024 | CooperVision Inc. | MyDay Contact Lens (Device) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Devices | ||||||
| 02/29/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: Dry eyes | ||||||
| 12/20/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $25.20 | General |
| Category: Ophthalmology | ||||||
| 11/10/2023 | CooperVision Inc. | MyDay Contact Lens (Device) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Devices | ||||||
| 10/19/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: DRY EYE | ||||||
| 05/26/2023 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Ophthalmology | ||||||
| 02/24/2023 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Ophthalmology | ||||||
| 12/20/2022 | CooperVision Inc. | MyDay Contact Lens (Device) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: Devices | ||||||
| 11/10/2022 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $11.70 | General |
| Category: DRY EYE | ||||||
| 10/20/2022 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/11/2022 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $12.22 | General |
| Category: DRY EYE | ||||||
| 09/15/2022 | Alcon Vision LLC | TOTAL30 (Device) | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: Ophthalmology | ||||||
| 08/09/2022 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: DRY EYE | ||||||
| 05/12/2022 | ABBVIE INC. | VUITY (Drug) | Food and Beverage | In-kind items and services | $28.12 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/27/2022 | Bausch & Lomb Americas Inc. | — | Food and Beverage | In-kind items and services | $18.28 | General |
| 12/14/2021 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug), ZYLET, LOTEPREDNOL ETABONATE | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Ophthalmology | ||||||
| 10/07/2021 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 141 | 151 | $16,135 | $6,334 |
| 2022 | 4 | 111 | 122 | $12,590 | $5,713 |
| 2021 | 6 | 118 | 126 | $14,030 | $8,041 |
| 2020 | 5 | 97 | 104 | $10,540 | $5,317 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 62 | 72 | $8,835 | $4,143 | 46.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 35 | 35 | $2,755 | $920.20 | 33.4% |
| 92250 | Photography of the retina | Office | 2023 | 30 | 30 | $3,150 | $679.17 | 21.6% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 14 | 14 | $1,395 | $592.54 | 42.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 45 | 53 | $5,565 | $3,107 | 55.8% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 17 | 17 | $2,465 | $1,371 | 55.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 27 | 30 | $2,250 | $741.34 | 32.9% |
| 92250 | Photography of the retina | Office | 2022 | 22 | 22 | $2,310 | $492.60 | 21.3% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 38 | 39 | $5,655 | $3,619 | 64.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 25 | 30 | $3,150 | $1,762 | 55.9% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 16 | 16 | $1,600 | $968.75 | 60.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 17 | 19 | $1,425 | $736.46 | 51.7% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 11 | 11 | $1,045 | $622.74 | 59.6% |
| 92250 | Photography of the retina | Office | 2021 | 11 | 11 | $1,155 | $333.16 | 28.8% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 36 | 36 | $4,965 | $2,763 | 55.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 21 | 25 | $2,425 | $1,269 | 52.3% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2020 | 14 | 14 | $1,355 | $825.96 | 61.0% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2020 | 12 | 14 | $970.00 | $264.90 | 27.3% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 14 | 15 | $825.00 | $194.23 | 23.5% |
About Dr. Michael Brownfield, O.D
Dr. Michael Brownfield, O.D is a Optometrist healthcare provider based in Latrobe, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760460364.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Brownfield, O.D has received a total of $1,676 in payments from pharmaceutical and medical device companies, with $315.87 received in 2024. These payments were reported across 92 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,676).
As a Medicare-enrolled provider, Brownfield has provided services to 467 Medicare beneficiaries, totaling 503 services with total Medicare billing of $25,406. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Optometrist
- Location Latrobe, PA
- Active Since 01/04/2006
- Last Updated 01/27/2020
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1760460364
Products in Payments
- XIIDRA (Drug) $497.77
- MyDay Contact Lens (Device) $153.13
- Clariti Contact Lens (Device) $121.91
- DAILIES (Device) $119.03
- RESTASIS (Drug) $116.07
- TOTAL30 (Device) $98.52
- TYRVAYA (Drug) $95.87
- ULTRA (Device) $91.31
- Acuvue (Device) $73.78
- VYZULTA (Drug) $60.24
- VUITY (Drug) $28.12
- Prokera (Device) $26.71
- Cequa (Drug) $25.20
- OXERVATE (Drug) $23.51
- VEVYE (Drug) $17.88
- Multiple Brands Contact Lens (Device) $16.54
- LOTEMAX (Drug) $15.99
- Biofinity Contact Lens (Device) $15.83
- MIEBO (Drug) $14.83
- Systane (Drug) $12.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Latrobe
Dr. Michelle Cove, O.d, O.D
Optometrist — Payments: $2,174
Matthew Christianson, O.d, O.D
Optometrist — Payments: $1,639
Lewis Carrarini, O.d, O.D
Optometrist — Payments: $1,418
Mrs. Jill Miller, Od, OD
Optometrist — Payments: $1,162
Dr. Robert Johnson Jr., O.d, O.D
Optometrist — Payments: $857.32
Dr. Andrew Miller, O.d, O.D
Optometrist — Payments: $829.10